Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

NCT02023463 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Goserelin acetate
DRUG: Leuprolide acetate
RADIATION: Radiation therapy

Sponsor

Thomas Jefferson University

Collaborators

[object Object]
[object Object]